Effects of Interferon-Gamma on Cavitary Pulmonary Tuberculosis in the Lungs
Status:
Completed
Trial end date:
2007-08-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the lung's immune response to mycobacterium tuberculosis (Mtb)
infection and will modulate that response with interferon-gamma.
Phase:
Phase 2
Details
Lead Sponsor:
New York University School of Medicine NYU Langone Health